An immunogenic WT1-derived peptide that induces T cell response in the context of HLA-A*02:01 and HLA-A*24:02 molecules
The Wilms' tumor oncogene protein (WT1) is a highly validated tumor antigen for immunotherapy. WT1-targeted immunotherapy has been extensively explored in multiple human trials in various cancers. However, clinical investigations using WT1 epitopes have generally focused on two peptides, HLA-re...
Main Authors: | Tao Dao, Tatyana Korontsvit, Victoria Zakhaleva, Casey Jarvis, Patrizia Mondello, Claire Oh, David A. Scheinberg |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-02-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/2162402X.2016.1252895 |
Similar Items
-
Cross-immunizing potential of tumor MAGE-A epitopes recognized by HLA-A*02:01-restricted cytotoxic T lymphocytes
by: Ze-Min Huang1,#, Zheng-Cai Jia2,#, Jun Tang3, Yi Zhang1, Yi Tian1, Dong-Jing Ni1, Fang Wang2, Yu-Zhang Wu1,* & Bing Ni1,*
Published: (2012-07-01) -
HLA-A*11:01:01:01, HLA-C*12:02:02:01-HLA-B*52:01:02:02, Age and Sex Are Associated With Severity of Japanese COVID-19 With Respiratory Failure
by: Seik-Soon Khor, et al.
Published: (2021-04-01) -
Induction of WT1 specific human CD8+ T cells from human HSCs in HLA class I Tg NOD/SCID/Il2rgKO mice
by: Najima, Yuho
Published: (2016) -
The HLA DPB1*02:01:02 and DQB1*05:02:01 alleles as possible risk factors for colorectal carcinoma in the Malaysian population
by: Nor Adzimah Johdi, et al.
Published: (2016) -
Kolon Poliplerinde WT1 Ekspresyonunun İncelenmesi
by: Ali Aslan, et al.
Published: (2018-05-01)